Introduction to
Tegoprazan:
Tegoprazan is a relatively new addition to the class of drugs known as proton pump inhibitors (PPIs). Marketed under trade names such as K-CAB, this medication has been developed primarily to treat conditions related to excessive stomach acid production. It has been extensively researched and is currently being used in South Korea, with ongoing studies to expand its approval and use in other countries. Tegoprazan targets the
H+/K+ ATPase enzyme system in gastric parietal cells, effectively controlling the secretion of gastric acid. The drug is indicated for the treatment of
gastroesophageal reflux disease (GERD),
peptic ulcers, and other
acid-related gastrointestinal disorders. Research conducted by institutions such as
CJ Healthcare has shown promising results, with data indicating that Tegoprazan offers a rapid onset of action and longer-lasting effects compared to traditional PPIs.
Tegoprazan Mechanism of Action:
Tegoprazan is a potassium-competitive acid blocker (P-CAB), which distinguishes it from the classical PPIs. While traditional PPIs irreversibly bind to the H+/K+ ATPase enzyme, Tegoprazan competes with potassium ions to block this enzyme's activity. This leads to a reversible and more controlled inhibition of gastric acid secretion. The drug effectively inhibits both meal-stimulated and nocturnal acid production, providing a more comprehensive management of acid-related disorders. Moreover, its ability to rapidly inhibit acid secretion shortly after administration gives it an advantage in providing quick relief from symptoms. This mechanism also allows for a more predictable pharmacokinetic profile, making it a versatile option for patients with varied dosing needs.
How to Use Tegoprazan:
Tegoprazan is typically administered orally in the form of tablets. The recommended dosage and duration of treatment depend on the specific condition being treated. For GERD, the usual dose is 50 mg once daily, taken before meals. In the case of peptic ulcers, the same dosage regimen is followed, but treatment duration may extend for several weeks based on the severity of the
ulcer. One of the key advantages of Tegoprazan is its rapid onset of action; patients often experience relief within 30 minutes to an hour after taking the medication. This feature makes it particularly beneficial for managing acute symptoms. It is crucial to follow the prescribed dosage and not to discontinue the medication abruptly, as doing so may result in a relapse of symptoms.
What is Tegoprazan Side Effects:
Like all medications, Tegoprazan is associated with certain side effects, although not everyone will experience them. Common side effects include
headache,
diarrhea,
abdominal pain, and
nausea. These effects are generally mild and tend to resolve on their own as the body adjusts to the medication. However, more serious side effects can occur, although they are rare. These may include severe
allergic reactions, such as
rash,
itching,
swelling, severe
dizziness, and
trouble breathing. Patients are advised to seek immediate medical attention if they experience any of these severe side effects. Tegoprazan is contraindicated in individuals with a known hypersensitivity to the drug or any of its components. Caution is also advised for patients with severe
liver impairment, as the drug is metabolized in the liver. Pregnant and breastfeeding women should consult their healthcare provider before starting Tegoprazan to weigh the potential benefits and risks.
What Other Drugs Will Affect Tegoprazan:
Tegoprazan can interact with other medications, potentially altering their effects or increasing the risk of adverse reactions. It is essential to inform your healthcare provider about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements. For instance, Tegoprazan may interact with drugs that are also metabolized by the liver, such as
warfarin, leading to altered blood levels of these medications and increasing the risk of
bleeding. Additionally, drugs that affect stomach acidity, such as antacids or
H2-receptor antagonists, may influence the absorption and effectiveness of Tegoprazan. Certain antibiotics like
clarithromycin and antifungal medications like
ketoconazole may also interact with Tegoprazan, requiring dosage adjustments or additional monitoring. By providing your healthcare provider with a comprehensive list of your current medications, you can help ensure that potential interactions are appropriately managed, optimizing the effectiveness and safety of your treatment.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


